US Broker Ratings

Baxter International Inc. (BAX) Stock Analysis: Navigating a Challenging Landscape with a 22% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is at a pivotal juncture as it navigates a challenging financial landscape. With a market capitalization of $9.96 billion,..

Novartis AG (NVS) Stock Analysis: Navigating a Stable Path Amidst Healthcare Giants

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, continues to draw investor attention with its robust market position and expansive pharmaceutical portfolio. Headquartered in Basel, Switzerland, Novartis..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Navigating a 14% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, stands out for investors seeking exposure to the pharmaceutical industry. With a market capitalization of $52.08 billion,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Discovering a 23.89% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is capturing investor attention with its robust growth potential and strategic position in the healthcare sector. With a market cap of $14.48 billion, this San..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Insulet Corporation (PODD) Stock Analysis: Robust Analyst Ratings Signal a Promising 30.87% Upside

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, focusing on innovative medical devices. With a market capitalization of $20.32 billion, the company is known for its..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Powerhouse with a Promising 3.99% Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a stalwart in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $49.49 billion, Cardinal Health..

Natera, Inc. (NTRA) Investor Outlook: Analysts Back Diagnostics Leader with a 5.36% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its innovative molecular testing services. Headquartered in Austin, Texas, Natera..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 19.96% Potential Upside for Investors

As an iconic name in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) stands at the forefront of health technology, offering a diverse portfolio that spans diagnostic imaging, connected care,..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring an 18% Upside Potential

Labcorp Holdings Inc. (NYSE: LH) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly within the diagnostics and research industry. As a key player..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a Robust Biotech with 1.33% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology sector, is capturing investor attention with its robust portfolio of medicines and innovative research initiatives. With a market capitalization..

Centene Corporation (CNC) Investor Outlook: Navigating Healthcare Challenges with a $19.91 Billion Market Cap

Centene Corporation (NYSE: CNC), a key player in the healthcare sector, continues to navigate a complex landscape as a provider of healthcare plans in the United States. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 81% Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical pioneer based in Miami, Florida, has captured investor attention with an impressive potential upside of 81.28%. Specializing in the discovery, development, and commercialization..

BeOne Medicines Ltd. (ONC) Stock Analysis: Discovering a 28% Upside in the Biotech Sector

Investors eyeing the healthcare sector have a promising candidate in BeOne Medicines Ltd. (ONC), a biotechnology firm based in Switzerland, with a substantial market capitalization of $34.57 billion. Known for..

Sanofi (SNY) Investor Outlook: Exploring a 22.45% Upside in a Challenging Market

Sanofi (NYSE: SNY), a titan in the global healthcare sector, is a noteworthy player in the drug manufacturing industry. With a rich history dating back to its incorporation in 1994,..

Merck & Company, Inc. (MRK) Stock Analysis: Robust Dividend and Promising Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to attract investor attention due to its significant market presence and robust financial performance. As a leader..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 12.57% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector specializing in diagnostics and research, is drawing attention from investors due to its robust market presence and promising upside..

Novo Nordisk A/S (NVO) Stock Analysis: Robust Revenue Growth and Attractive Dividend Yield

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to stand out with its strong financial performance and strategic focus on..

Medtronic plc (MDT) Stock Analysis: A 14.97% Potential Upside with Strong Dividend Appeal

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, continues to command investor attention with its sizable market presence and robust product portfolio. As a key player in..

Eli Lilly and Company (LLY) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Optimism

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its impressive market cap of $966.16 billion. This pharmaceutical giant, headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds